A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors

References

• Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6 - 21; http://dx.doi.org/10.1101/gad.947102; PMID: 11782440
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415 - 28; PMID: 12042769
   PubMed Web of Science ®Google Scholar
• De Smet C, Loriot A. DNA hypomethylation and activation of germline-specific genes in cancer. Adv Exp Med Biol 2013; 754:149 - 66; http://dx.doi.org/10.1007/978-1-4419-9967-2_7; PMID: 22956500
   PubMed Web of Science ®Google Scholar
• Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5:615 - 25; http://dx.doi.org/10.1038/nrc1669; PMID: 16034368
   PubMed Web of Science ®Google Scholar
• Cannuyer J, Loriot A, Parvizi GK, De Smet C. Epigenetic hierarchy within the MAGEA1 cancer-germline gene: promoter DNA methylation dictates local histone modifications. PLoS One 2013; 8:e58743; http://dx.doi.org/10.1371/journal.pone.0058743; PMID: 23472218
   PubMedGoogle Scholar
• De Smet C, Lurquin C, Lethé B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999; 19:7327 - 35; PMID: 10523621
   PubMed Web of Science ®Google Scholar
• Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10:704 - 14; http://dx.doi.org/10.1038/nrg2634; PMID: 19763153
   PubMed Web of Science ®Google Scholar
• Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 2011; 585:2087 - 99; http://dx.doi.org/10.1016/j.febslet.2010.08.009; PMID: 20708002
   PubMed Web of Science ®Google Scholar
• Liu Y, Guo F, Dai M, Wang D, Tong Y, Huang J, Hu J, Li G. Gammaaminobutyric acid A receptor alpha 3 subunit is overexpressed in lung cancer. Pathol Oncol Res 2009; 15:351 - 8; http://dx.doi.org/10.1007/s12253-008-9128-7; PMID: 19048400
   PubMed Web of Science ®Google Scholar
• Liu Y, Li YH, Guo FJ, Wang JJ, Sun RL, Hu JY, Li GC. Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit. World J Gastroenterol 2008; 14:7175 - 82; http://dx.doi.org/10.3748/wjg.14.7175; PMID: 19084931
   PubMed Web of Science ®Google Scholar
• Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, Yang P, Sun Z, Szoke J, Gerald WL, Watson M, et al. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med 2006; 3:e467; http://dx.doi.org/10.1371/journal.pmed.0030467; PMID: 17194181
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang R, Zheng Y, Shen J, Xiao D, Li J, Shi X, Huang L, Tang H, Liu J, et al. Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. J Transl Med 2013; 11:102; http://dx.doi.org/10.1186/1479-5876-11-102; PMID: 23617850
   PubMed Web of Science ®Google Scholar
• Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O’Connor ST, Chin AR, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014; 25:501 - 15; http://dx.doi.org/10.1016/j.ccr.2014.03.007; PMID: 24735924
   PubMed Web of Science ®Google Scholar
• Pfeifer GP, Kadam S, Jin SG. 5-hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin 2013; 6:10; http://dx.doi.org/10.1186/1756-8935-6-10; PMID: 23634848
   PubMed Web of Science ®Google Scholar
• Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010; 466:1129 - 33; http://dx.doi.org/10.1038/nature09303; PMID: 20639862
   PubMed Web of Science ®Google Scholar
• Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324:930 - 5; http://dx.doi.org/10.1126/science.1170116; PMID: 19372391
   PubMed Web of Science ®Google Scholar
• Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010; 468:839 - 43; http://dx.doi.org/10.1038/nature09586; PMID: 21057493
   PubMed Web of Science ®Google Scholar
• Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012; 150:1135 - 46; http://dx.doi.org/10.1016/j.cell.2012.07.033; PMID: 22980977
   PubMed Web of Science ®Google Scholar
• Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, Xu ZD, Zhu HG, Ling ZQ, Ye D, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013; 32:663 - 9; http://dx.doi.org/10.1038/onc.2012.67; PMID: 22391558
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010; 18:553 - 67; http://dx.doi.org/10.1016/j.ccr.2010.11.015; PMID: 21130701
   PubMed Web of Science ®Google Scholar
• Hsu CH, Peng KL, Kang ML, Chen YR, Yang YC, Tsai CH, Chu CS, Jeng YM, Chen YT, Lin FM, et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep 2012; 2:568 - 79; http://dx.doi.org/10.1016/j.celrep.2012.08.030; PMID: 22999938
   PubMed Web of Science ®Google Scholar
• Cheng J, Guo S, Chen S, Mastriano SJ, Liu C, D’Alessio AC, Hysolli E, Guo Y, Yao H, Megyola CM, et al. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis. Cell Rep 2013; 5:471 - 81; http://dx.doi.org/10.1016/j.celrep.2013.08.050; PMID: 24120864
   PubMed Web of Science ®Google Scholar
• Song SJ, Ito K, Ala U, Kats L, Webster K, Sun SM, Jongen-Lavrencic M, Manova-Todorova K, Teruya-Feldstein J, Avigan DE, et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 2013; 13:87 - 101; http://dx.doi.org/10.1016/j.stem.2013.06.003; PMID: 23827711
   PubMed Web of Science ®Google Scholar
• Song SJ, Poliseno L, Song MS, Ala U, Webster K, Ng C, Beringer G, Brikbak NJ, Yuan X, Cantley LC, et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 2013; 154:311 - 24; http://dx.doi.org/10.1016/j.cell.2013.06.026; PMID: 23830207
   PubMed Web of Science ®Google Scholar
• Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C, Figueroa ME, Vasanthakumar A, Patel J, Zhao X, et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011; 20:11 - 24; http://dx.doi.org/10.1016/j.ccr.2011.06.001; PMID: 21723200
   PubMed Web of Science ®Google Scholar
• Quivoron C, Couronné L, Della Valle V, Lopez CK, Plo I, Wagner-Ballon O, Do Cruzeiro M, Delhommeau F, Arnulf B, Stern MH, et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011; 20:25 - 38; http://dx.doi.org/10.1016/j.ccr.2011.06.003; PMID: 21723201
   PubMed Web of Science ®Google Scholar
• Zha R, Guo W, Zhang Z, Qiu Z, Wang Q, Ding J, Huang S, Chen T, Gu J, Yao M, et al. Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma. PLoS One 2014; 9:e87665; http://dx.doi.org/10.1371/journal.pone.0087665; PMID: 24498348
   PubMed Web of Science ®Google Scholar
• Williams K, Christensen J, Helin K. DNA methylation: TET proteins-guardians of CpG islands?. EMBO Rep 2012; 13:28 - 35; http://dx.doi.org/10.1038/embor.2011.233; PMID: 22157888
   PubMed Web of Science ®Google Scholar
• Hackett JA, Sengupta R, Zylicz JJ, Murakami K, Lee C, Down TA, Surani MA. Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science 2013; 339:448 - 52; http://dx.doi.org/10.1126/science.1229277; PMID: 23223451
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Shen L, Liu Y, Sendler D, Zhang Y. Role of Tet1 in erasure of genomic imprinting. Nature 2013; 504:460 - 4; http://dx.doi.org/10.1038/nature12805; PMID: 24291790
   PubMed Web of Science ®Google Scholar
• Gjerstorff MF, Kock K, Nielsen O, Ditzel HJ. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development. Hum Reprod 2007; 22:953 - 60; http://dx.doi.org/10.1093/humrep/del494; PMID: 17208940
   PubMed Web of Science ®Google Scholar
• Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Müntefering H, Huber C, Sahin U, Türeci O. Frequent nonrandom activation of germ-line genes in human cancer. Cancer Res 2004; 64:5988 - 93; http://dx.doi.org/10.1158/0008-5472.CAN-04-1187; PMID: 15342378
   PubMed Web of Science ®Google Scholar
• Maatouk DM, Kellam LD, Mann MR, Lei H, Li E, Bartolomei MS, Resnick JL. DNA methylation is a primary mechanism for silencing postmigratory primordial germ cell genes in both germ cell and somatic cell lineages. Development 2006; 133:3411 - 8; http://dx.doi.org/10.1242/dev.02500; PMID: 16887828
   PubMed Web of Science ®Google Scholar
• Jin SG, Wu X, Li AX, Pfeifer GP. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res 2011; 39:5015 - 24; http://dx.doi.org/10.1093/nar/gkr120; PMID: 21378125
   PubMed Web of Science ®Google Scholar
• Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming GL, King JR, Song H, Sweatt JD. TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 2013; 79:1086 - 93; http://dx.doi.org/10.1016/j.neuron.2013.08.032; PMID: 24050399
   PubMed Web of Science ®Google Scholar
• Rudenko A, Dawlaty MM, Seo J, Cheng AW, Meng J, Le T, Faull KF, Jaenisch R, Tsai LH. Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 2013; 79:1109 - 22; http://dx.doi.org/10.1016/j.neuron.2013.08.003; PMID: 24050401
   PubMed Web of Science ®Google Scholar
• Loriot A, Parvizi GK, Reister S, De Smet C. Silencing of cancer-germline genes in human preimplantation embryos: evidence for active de novo DNA methylation in stem cells. Biochem Biophys Res Commun 2012; 417:187 - 91; http://dx.doi.org/10.1016/j.bbrc.2011.11.120; PMID: 22155245
   PubMed Web of Science ®Google Scholar
• Davis LG, Dibner MD, Battey JF. Basic methods in molecular biology. New York: Elsevier, 1986.
   Google Scholar
• De Smet C, Loriot A, Boon T. Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol Cell Biol 2004; 24:4781 - 90; http://dx.doi.org/10.1128/MCB.24.11.4781-4790.2004; PMID: 15143172
   PubMed Web of Science ®Google Scholar
• De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci U S A 1996; 93:7149 - 53; http://dx.doi.org/10.1073/pnas.93.14.7149; PMID: 8692960
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489:519 - 25; http://dx.doi.org/10.1038/nature11404; PMID: 22960745
   PubMed Web of Science ®Google Scholar